Ticker
FDMTCompany Name
4D MOLECULAR THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 258.26M | $ 2.03M | $ 0 | $ 0 | -0.79% |
3/31/2025 | $ 150.09M | $ 18.42M | $ 0 | $ 0 | -12.27% |
12/31/2024 | $ 209.75M | $ 337.25M | $ 0 | $ 0 | -160.79% |
9/30/2024 | $ 356.42M | $ 341.41M | $ 0 | $ 0 | -95.79% |
6/30/2024 | $ 765.51M | $ 350.86M | $ 0 | $ 0 | -45.83% |
3/31/2024 | $ 1.33B | $ 464.6M | $ 0 | $ 0 | -35.05% |
12/31/2023 | $ 1.39B | $ 156.83M | $ 0 | $ 0 | -11.24% |
9/30/2023 | $ 448.91M | $ 154.58M | $ 0 | $ 0 | -34.44% |
6/30/2023 | $ 716.58M | $ 144.67M | $ 0 | $ 0 | -20.19% |
3/31/2023 | $ 562.1M | $ 13.74M | $ 0 | $ 0 | -2.44% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for 4D MOLECULAR THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 206.51M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 1.06B ]
(=) Shareholder Yield [ -19.57% ]
Minimum
Dec 31, 2024
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.49K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |